U.S. Household Products Stock News

NYSE:FTI
NYSE:FTIEnergy Services

TechnipFMC (FTI) Is Up 7.7% After New Subsea Contract Win With Azule Energy

TechnipFMC plc recently announced it had secured a “significant” contract, valued between US$75 million and US$250 million, from Azule Energy to design and manufacture flexible flowlines, risers, and related equipment for the West Hub Tails extension of the Block 15/06 Agogo Integrated Development. This award, which will be booked into third-quarter 2026 inbound orders, highlights TechnipFMC’s role in consolidating West Hub production through the Agogo FPSO, reinforcing demand for its core...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

Can BBB Foods’ (TBBB) Expansion-Driven Losses Clarify Its Long-Term Capital Allocation Playbook?

BBB Foods Inc. has already reported its second-quarter 2026 results, with revenue rising to MX$26,037.29 million while net loss widened to MX$386.34 million, and separately filed a US$1.53 billion shelf registration for up to 37,640,312 Class A shares related to an employee stock plan. Despite reporting losses for both the quarter and first half of 2026, the company is rapidly expanding its Mexican store base and improving cash flow, while insiders’ non-discretionary share sales to cover tax...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Will Harrow’s (HROW) TYRVAYA Deal and Reaffirmed 2026 Guidance Redefine Its Dry Eye Strategy?

In August 2026, Harrow, Inc. reported second-quarter revenue of US$70.66 million versus US$63.74 million a year earlier, swung to a net loss of US$17.27 million, and reiterated its 2026 revenue guidance of US$350 million to US$365 million. Just days earlier, Harrow agreed to acquire TYRVAYA nasal spray for up to US$100 million, aiming to broaden its dry eye disease franchise with a drop-free treatment that complements its existing VEVYE offering. Next, we’ll examine how reaffirmed 2026...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

Agios Pharmaceuticals (AGIO) Could Be 24% Undervalued On PYRUKYND Growth Hopes

Agios Pharmaceuticals (AGIO) has drawn investor focus after recent trading left the stock at a last close of $33.63. With mixed return figures across different periods, the company’s rare disease portfolio is gaining fresh attention. See our latest analysis for Agios Pharmaceuticals. Over the past year, Agios Pharmaceuticals has combined a 23.73% year to date share price return with a 21.28% 90 day share price gain, yet the 1 year total shareholder return declined 10.20%. This suggests that...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback

In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$97.19 million share repurchase program under its February 2026 authorization while also announcing a new up to US$100 million buyback. The company also raised its full-year 2026 revenue outlook to a range of US$1.69 billion to US$1.73 billion, signaling management’s confidence alongside this...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Tarsus Pharmaceuticals (TARS) Shares Just Moved, What Is Behind The Attention?

Why Tarsus Pharmaceuticals stock is in focus after Q2 2026 Tarsus Pharmaceuticals (TARS) is back on investors radar after its Q2 2026 earnings report showed higher revenue, a smaller net loss, and a higher full year sales outlook for XDEMVY. See our latest analysis for Tarsus Pharmaceuticals. Tarsus Pharmaceuticals shares have reacted positively to the Q2 2026 update, with a 17.99% 1 month share price return and a 15.21% 3 month share price return, while the year to date share price is still...
NYSE:NPK
NYSE:NPKAerospace & Defense

National Presto Industries (NPK) Climbed, What Is Catching Investors' Attention?

National Presto Industries (NPK) is back in focus after reporting second quarter and first half 2026 results that showed higher sales, net income, and earnings per share compared with the same periods last year. See our latest analysis for National Presto Industries. National Presto Industries’ latest earnings announcement has coincided with a strong run in the stock, with a 30 day share price return of 18.71% and a 1 year total shareholder return of 40.49%. This suggests momentum has been...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Etsy (ETSY) Back In Focus Following Mixed Earnings And A Full Valuation View

Why Etsy stock is back in focus after mixed second quarter results Etsy (ETSY) has moved back onto investor watchlists after reporting second quarter 2026 earnings that combined higher sales with a shift to a net loss, alongside a return to profitability over the first half of the year. See our latest analysis for Etsy. Etsy's recent earnings announcement and its upcoming appearance at the Canaccord Genuity Growth Conference have arrived after a strong 90 day share price return of 36.1%, even...
NYSE:ST
NYSE:STElectrical

Sensata Technologies Holding (ST) Could Be 13% Undervalued Following Mixed Q2 Earnings

Sensata Technologies Holding (ST) has drawn fresh attention after its latest Q2 earnings report, where revenue grew 5% year on year and beat expectations, inventory metrics improved, yet forward guidance lagged sector peers. See our latest analysis for Sensata Technologies Holding. At a latest share price of US$45.92, Sensata Technologies Holding has seen a strong year to date, with a 31.61% share price return and a 43.68% total shareholder return over the past year, even as the 90 day share...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

How Stronger Q2 Results And New Shelf Filing At Fastly (FSLY) Have Changed Its Investment Story

In early August 2026, Fastly, Inc. reported second-quarter sales of US$183.32 million with a reduced net loss of US$15.59 million, and subsequently filed an omnibus shelf registration covering debt securities, preferred stock, Class A common stock, and warrants. Alongside these results, Fastly raised its full-year 2026 revenue guidance to US$732.0 million–US$746.0 million, signaling management’s confidence while also securing flexibility to access capital markets through the new shelf...
NYSE:BXC
NYSE:BXCTrade Distributors

3 U.S. Industrials That Could Gain If Tariffs Hit Canadian Metals And Lumber

With the clock ticking on potential 50% U.S. tariffs on Canadian goods, investors are watching domestic industrials in a new light. Companies with U.S. heavy operations and lower Canada revenue exposure could face a very different trade impact than cross border peers, for better or worse. This article walks through 3 stocks from that group and explains how the current tariff standoff might affect each one. The sample of stocks below is only a starting point, since the full screen surfaced 61...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Stronger Q1 Earnings and Higher Dividend Target Could Be A Game Changer For Hamilton Lane (HLNE)

Hamilton Lane’s August 4, 2026 report showed first‑quarter revenue of US$275.33 million and net income of US$80.46 million, with basic earnings per share from continuing operations of US$1.94, all higher than the same period a year earlier. At the same time, the company declared a quarterly dividend of US$0.60 per Class A share, lifting its full‑year dividend target by 11%, which underscores management’s confidence in current cash flows and capital‑return capacity. We’ll now examine how this...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Stronger 2026 Outlook After Mixed Q2 Results Might Change The Case For Investing In ACAD (ACAD)

In August 2026, ACADIA Pharmaceuticals Inc. reported past second-quarter 2026 results showing revenue of US$307.96 million and net income of US$31.5 million, with earnings per share from continuing operations of US$0.18, alongside higher year-to-date revenue but lower net income compared with the same period in 2025. On the same day, the company raised its full-year 2026 guidance, lifting projected total revenues to US$1.24–US$1.30 billion and increasing expected DAYBUE global net product...
NYSE:ENVA
NYSE:ENVAConsumer Finance

Does Enova’s Earnings Beat And 52-Week High Change The Bull Case For Enova International (ENVA)?

Enova International recently hit a new 52-week high after reporting earnings that again surpassed consensus estimates, extending its streak of positive surprises. This performance, alongside a Zacks Rank #2 (Buy) and an Average Broker Recommendation of #1 (Strong Buy), highlights increasingly supportive analyst sentiment around its fundamentals and growth outlook. Against this backdrop of stronger earnings and upgraded sentiment, we'll examine how the recent results might reshape Enova...
NYSE:IQV
NYSE:IQVLife Sciences

Does IQVIA’s Cardiac Gene Therapy Partnership Deepen Its Moat In Human-Based Drug Development (IQV)?

On 4 August 2026, Medera Inc. announced a collaboration with IQVIA Inc. to combine IQVIA’s global clinical trial and commercialization capabilities with Medera’s Sardocor gene therapy programs and Novoheart’s engineered human cardiac tissue platform for drug discovery and safety testing. By pairing IQVIA’s regulatory and trial execution expertise with Medera’s human-based disease modelling technologies, the partnership underscores how IQVIA is embedding itself deeper into emerging areas like...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Is Steel Dynamics (STLD) Undervalued On Its Leadership Transition And Growth Plans?

Steel Dynamics (STLD) has outlined an extensive leadership transition that will appoint long-serving executive Theresa E. Wagler as CEO and President effective January 1, 2027, along with broader C suite realignments. See our latest analysis for Steel Dynamics. At a share price of US$258.16, Steel Dynamics has seen solid momentum, with a 30 day share price return of 9.62% and year to date share price return of 46.63%, alongside a 1 year total shareholder return of 107.49%. These leadership...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Semtech (SMTC) After Needham Repeats Buy Rating While AI Demand Keeps Valuation In Focus

Semtech (SMTC) drew fresh attention on 17 August 2026 after a Needham analyst reiterated a positive rating on the stock, highlighting demand trends in data center networking and IoT connectivity that continue to interest investors. See our latest analysis for Semtech. For context, Semtech’s share price has climbed 9.88% in the last day and 104.92% year to date, with a 1 year total shareholder return of 205.87%. This suggests strong, sustained momentum around the company’s data center and IoT...
NYSE:KVYO
NYSE:KVYOSoftware

Should Klaviyo’s (KVYO) Strong Q2, Raised Guidance and AI Agency Deal Prompt Investor Reassessment?

Klaviyo, Inc. reported past second-quarter 2026 results with revenue of US$370.58 million and a narrower net loss of US$8.85 million, while also issuing higher full-year revenue guidance and confirming third-quarter expectations. The company is pairing this improved financial profile with AI-focused expansion, acquiring Agency’s team and technology and appointing founder Elias Torres as Chief Product Officer to accelerate its agent product line. We’ll now examine how Klaviyo’s raised...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

IDEAYA Biosciences (IDYA) Reports Second Quarter Results, Is The Valuation Still Justified?

IDEAYA Biosciences (IDYA) recently released its second quarter 2026 results, reporting revenue of US$8.86 million and a net loss of US$112.45 million. These figures, together with wider losses per share, are influencing how investors reassess the stock. See our latest analysis for IDEAYA Biosciences. The latest earnings release appears to be a key reference point for IDEAYA Biosciences, with the 90 day share price return of 29.03% and 1 year total shareholder return of 47.64% signalling...
NasdaqGS:AUGO
NasdaqGS:AUGOMetals and Mining

Aura Minerals (NasdaqGS:AUGO) Shares Jumped, What Is Behind The Move?

Aura Minerals (AUGO) just reported quarterly and half year results that show higher sales and a sharp swing to profit, while also reaffirming its 2026 production targets to give investors clearer visibility. See our latest analysis for Aura Minerals. The strong earnings release, dividend declaration and recent buyback have come alongside a sharp move in Aura Minerals' stock, with a 30 day share price return of 56.39% and a one year total shareholder return of 188.55% signalling strong...
NYSE:MOG.A
NYSE:MOG.AAerospace & Defense

Can Moog (MOG.A) Justify Its Valuation After Opening Its New AIM Facility?

Moog stock reacts to new AIM facility opening and 75th anniversary milestone Moog (MOG.A) has drawn fresh investor attention after opening its new Advanced Integrated Manufacturing facility in Western New York. The $150 million project is timed with the company’s 75th anniversary celebrations. See our latest analysis for Moog. The AIM facility opening sits alongside a powerful share price run for Moog, with a 90 day share price return of 46.43% and a year to date share price return of 78.24%...
NYSE:RES
NYSE:RESEnergy Services

Oil Stocks To Watch As Brent Nears $90 And Supply Risks Return

Oil is back in the spotlight as Brent edges toward US$90, inflation worries return and war with Iran keeps traders on alert about global supply. At the same time, higher US Treasury yields are pressuring valuations while strong earnings keep stocks near record highs. This article walks through 3 large energy producers that screens suggest are most exposed to this mix of rising crude, rates and profit expectations. The 3 stocks below are just a starting sample, and the full screen surfaced 8...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

US$675 Million Refinancing Could Be A Game Changer For Chefs' Warehouse (CHEF)

The Chefs' Warehouse, Inc. previously began a refinancing process, marketing and later upsizing a new US$675 million term loan facility to refinance existing debt, redeem convertible notes, fund capital expenditures, and support general corporate purposes. This prospective refinancing could meaningfully reshape the company’s capital structure by consolidating borrowings into a single term loan while potentially extending maturities and increasing financial flexibility. We’ll now examine how...